AVDL AVADEL PHARMACEUTICALS PLC Capital Structure Changes 8-K Filing 2023 - Exchange Agreements Avadel Pharmaceuticals has entered into exchange agreements to exchange $96.2 million of its outstanding 4.50% exchangeable senior notes due October 2, 2023 for new 6.00% exchangeable senior notes due April 1, 2027.Get access to all SEC 8-K filings of the AVADEL PHARMACEUTICALS PLC